A Regulatory Perspective: Integrating PIM into the Product Lifecycle

Pharma IQ

Helen Winsor from Pharma IQ, speaks to Dr. Andrew Marr, Director of e-Regulatory Development and Global Regulatory Operations and Co-Chair of the PIM Steering Committee on behalf of the EFPIA.  In this interview, he addresses the latest developments in Project Information Management (PIM) and gives an overview of why it is important to prepare before implementing PIM. Dr. Marr also outlines the main challenges faced and the lessons learned so far by trial groups – and talks in depth about t...
To continue reading this story get free access